LivaNova PLC Amortization
LivaNova PLC (LIVN) reported Amortization of $10.27 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-04-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2020-04-30
- LivaNova PLC amortization for the quarter ending 2020-03-31 was $10.27M, a 10.21% increase year-over-year.
- LivaNova PLC amortization for the quarter ending 2019-12-31 was $10.69M, a 16.88% increase year-over-year.
- LivaNova PLC amortization for the quarter ending 2019-09-30 was $11.15M, a 18.03% increase year-over-year.
- LivaNova PLC amortization for the quarter ending 2019-06-30 was $9.23M, a 5.90% decline year-over-year.
- LivaNova PLC amortization for fiscal 2019 was $40.38M, a 8.55% increase from fiscal 2018.
- LivaNova PLC amortization for fiscal 2018 was $37.19M, a 18.93% decline from fiscal 2017.
- LivaNova PLC amortization for fiscal 2017 was $45.88M, a 0.81% increase from fiscal 2016.
- LivaNova PLC amortization for fiscal 2016 was $45.51M.
| Period end | Amortization 3 month | Amortization 6 month | Amortization 9 month | Amortization 12 month |
|---|---|---|---|---|
| 2020-03-31 | $10.27M 10-Q · filed 2020-04-30 | $20.95M derived: sum of 2 quarters · filed 2020-04-30 | $32.10M derived: sum of 3 quarters · filed 2020-04-30 | $41.33M derived: sum of 4 quarters · filed 2020-04-30 |
| 2019-12-31 | $10.69M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $21.83M derived: sum of 2 quarters · filed 2020-03-02 | $31.06M derived: sum of 3 quarters · filed 2020-03-02 | $40.38M 10-K · filed 2020-03-02 |
| 2019-09-30 | $11.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $20.37M derived: sum of 2 quarters · filed 2019-10-30 | $29.69M 10-Q · filed 2019-10-30 | $38.83M derived: sum of 4 quarters · filed 2020-04-30 |
| 2019-06-30 | $9.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $18.54M 10-Q · filed 2019-07-31 | $27.69M derived: sum of 3 quarters · filed 2020-04-30 | $37.13M derived: sum of 4 quarters · filed 2020-04-30 |
| 2019-03-31 | $9.32M 10-Q · filed 2020-04-30 | $18.46M derived: sum of 2 quarters · filed 2020-04-30 | $27.90M derived: sum of 3 quarters · filed 2020-04-30 | $37.71M derived: sum of 4 quarters · filed 2020-04-30 |
| 2018-12-31 | $9.14M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $18.59M derived: sum of 2 quarters · filed 2020-03-02 | $28.39M derived: sum of 3 quarters · filed 2020-03-02 | $37.19M 10-K · filed 2020-03-02 |
| 2018-09-30 | $9.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $19.25M derived: sum of 2 quarters · filed 2019-10-30 | $28.05M 10-Q · filed 2019-10-30 | $38.49M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $9.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $18.61M 10-Q · filed 2019-07-31 | $29.05M derived: sum of 3 quarters · filed 2020-03-02 | $41.40M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $8.80M 10-Q · filed 2019-05-01 | $19.24M derived: sum of 2 quarters · filed 2020-03-02 | $31.59M derived: sum of 3 quarters · filed 2020-03-02 | $43.27M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $10.44M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $22.79M derived: sum of 2 quarters · filed 2020-03-02 | $34.47M derived: sum of 3 quarters · filed 2020-03-02 | $45.88M 10-K · filed 2020-03-02 |
| 2017-09-30 | $12.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $24.03M derived: sum of 2 quarters · filed 2018-11-01 | $35.45M 10-Q · filed 2018-11-01 | $47.00M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-06-30 | $11.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $23.09M 10-Q · filed 2018-08-02 | $34.65M derived: sum of 3 quarters · filed 2019-03-18 | $46.42M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-03-31 | $11.41M 10-Q · filed 2018-05-03 | $22.97M derived: sum of 2 quarters · filed 2019-03-18 | $34.74M derived: sum of 3 quarters · filed 2019-03-18 | $44.27M derived: sum of 4 quarters · filed 2019-03-18 |
| 2016-12-31 | $11.55M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $23.33M derived: sum of 2 quarters · filed 2019-03-18 | $32.86M derived: sum of 3 quarters · filed 2019-03-18 | $45.51M 10-K · filed 2019-03-18 |
| 2016-09-30 | $11.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $21.31M derived: sum of 2 quarters · filed 2017-11-02 | $33.96M 10-Q · filed 2017-11-02 | |
| 2016-06-30 | $9.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $22.18M 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | $12.65M 10-Q · filed 2017-05-03 | |||
| 2015-10-18 | $510.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $1.00M 10-Q · filed 2016-11-02 | ||
| 2015-07-24 | $494.00K 10-Q · filed 2016-08-05 | |||
| 2015-04-24 | $1.50M 10-KT · filed 2016-03-04 | |||
| 2014-04-25 | $1.30M 10-KT · filed 2016-03-04 | |||
| 2013-04-26 | $900.00K 10-KT · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |